0
0

Department of Veterans Affairs Awarded a Contract to SEQIRUS USA INC for $51,637,946.01

Signed on

11/20/2024, 12:00 AM

SEQIRUS USA INC Government Contract #36E79725D0006

SEQIRUS USA INC was awarded a contract with the United States Government for $51,637,946.01. The contract was awarded by the agency office NAC PHARMACEUTICALS (36E797), which is a division with the Department of Veterans Affairs within the Department of Veterans Affairs.

Summary of Award

The recipient of the government contract is Seqirus USA Inc, a foreign-owned business incorporated in the U.S. They are a manufacturer of pharmaceutical products. The contract, funded by the Department of Veterans Affairs, is for the influenza virus vaccine for the 2025-2026 flu season. The contract is worth $51,637,946.01. There are no notable spending patterns or transactions listed for this contract.

Contract Details

Contract ID36E79725D0006
Contract TypeIDV_B_A
Total Obligation$0.00
Exercised Options
Base Amount + Options$51,637,946.01
Date Signed2024-11-20
Contract DescriptionNEW AWARD FOR THE INFLUENZA VIRUS VACCINE FOR THE 2025-2026 FLU SEASON WITH SEQIRUS USA INC. THE PERIOD OF PERFORMANCE IS 03/15/2025 - 03/14/2026.
Start Date2025-03-15
End Date2026-03-14

Agency Details

Awarding AgencyDepartment of Veterans Affairs
Awarding Sub AgencyDepartment of Veterans Affairs
Awarding OfficeNAC PHARMACEUTICALS (36E797)
Funding AgencyDepartment of Veterans Affairs
Funding Sub AgencyDepartment of Veterans Affairs
Funding OfficeNAC PHARMACEUTICALS (36E797)

Recipient Details

RecipientSEQIRUS USA INC
Recipient Location25 DEFOREST AVE STE 200 SUMMIT NEW JERSEY, UNITED STATES
Business CategoriesCategory Business, Corporate Entity Not Tax Exempt, Foreign Owned, Foreign-Owned and U.S.-Incorporated Business, Manufacturer of Goods, Not Designated a Small Business, Special Designations

Comments

Award Transactions